RIFIZOSTREP – A NEW COMBINED PREPARATE AGAINST TUBERCULOSIS MICOBACTERS
نویسندگان
چکیده
The article presents the results of in vivo laboratory tests a new «Rifizostrep» anti-TB drug. organism experimentally infected 27 guinea pigs. It is obtained that preparation pigs at 10 мg/кg dose has sufficient antimicrobial activity against mycobacterium tuberculosis type M. bo-vis and
منابع مشابه
Vaccine against tuberculosis: what’s new?
BACKGROUND one of the World Health Organization Millennium Development Goal is to reduce tuberculosis incidence by 2015. However, more of 8.5 million tuberculosis cases have been reported in 2011, with an increase of multidrug-resistant strains. Therefore, the World Health Organization target cannot be reach without the help of a vaccine able to limit the spread of tuberculosis. Nowadays, bacil...
متن کاملActivity of carbapenems combined with clavulanate against murine tuberculosis.
Although beta-lactam antibiotics are not considered as antituberculous drugs, it has been recently shown that the combination of carbapenems and clavulanate is bactericidal in vitro. We evaluated in a murine model of tuberculosis the activity of carbapenems alone and combined with clavulanate against Mycobacterium tuberculosis. Swiss mice infected intravenously with 3 x 10⁵ M. tuberculosis H37R...
متن کاملProspects for new vaccines against tuberculosis.
The spectacular failure of the existing bacille Calmette-Guérin (BCG) vaccine in recent tuberculosis-control trials has prompted a search for potential replacements. Imaginative approaches currently under development include the modulation of BCG by the production of auxotrophic mutants or cytokine-secreting recombinants, and the development of subunit vaccines based on the major proteins of My...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Èpizootologiâ, immunobiologiâ, farmakologiâ, sanitariâ
سال: 2022
ISSN: ['2224-168X']
DOI: https://doi.org/10.47612/2224-168x-2022-2-52-57